Topics
Pediatric CNS tumors | Treatment | Clinical trials | Dabrafenib
Home > Publications > Topics > Pediatric CNS tumors > Treatment > Clinical trials > Dabrafenib
Wahid MA, Khan MT, Hussain JM, Malik H, Umar SA, Mughal S,
Hasanain M, Anjum MU, Mahmmoud Fadelallah Eljack M.
Emerging
paradigm: Molecularly targeted therapy with Dabrafenib and
Trametinib in recurring pediatric gliomas with BRAF mutations: A
narrative review.
Medicine
(Baltimore). 2024 Dec 6;103(49):e40735. doi:
10.1097/MD.0000000000040735. PMID:
39654184. Review. ˍ